Edesa Biotech annual operating margin
2014
2015
2016
2017
2020
Edesa Biotech Operating Margin Growth & History (EDSA)
Edesa Biotech's operating margin was −1,946.72% for fiscal 2020.
View full Edesa Biotech company overviewEdesa Biotech annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2020 | 2020-09-30 | −1,946.72% | +8502.37 pp |
| 2017 | 2017-09-30 | −10,449.09% | −10063.12 pp |
| 2016 | 2016-09-30 | −385.97% | +185.88 pp |
| 2015 | 2015-09-30 | −571.85% | +964.84 pp |
| 2014 | 2014-08-31 | −1,536.69% | — |
Edesa Biotech quarterly operating margin
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q1.18
Q2.18
Q3.19
Q1.20
Q2.20
Q3.20
Q4.20
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2020 | 2020-09-30 | −402,094.80% | −138024.00 pp |
| Q3 2020 | 2020-06-30 | −1,607.89% | +490.19 pp |
| Q2 2020 | 2020-03-31 | −1,371.98% | +5412.22 pp |
| Q1 2020 | 2019-12-31 | −1,025.68% | +795.29 pp |
| Q3 2019 | 2019-06-30 | −264,070.80% | −263073.68 pp |
| Q2 2018 | 2018-03-31 | −2,098.07% | −1621.23 pp |
| Q1 2018 | 2017-12-31 | −6,784.20% | −6127.92 pp |
| Q2 2017 | 2017-03-31 | −1,820.97% | −1485.14 pp |
| Q1 2017 | 2016-12-31 | −997.12% | −729.31 pp |
| Q4 2016 | 2016-09-30 | −476.85% | — |
| Q3 2016 | 2016-06-30 | −656.28% | — |
| Q2 2016 | 2016-03-31 | −335.83% | — |
| Q1 2016 | 2015-12-31 | −267.81% | — |
Edesa Biotech operating margin trends
Across the available reported history, Edesa Biotech's operating margin increased from −10,449.09% to −1,946.72%, a change of +8502.37 percentage points. The latest reported quarter, Q4 2020, shows −402,094.80%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Edesa Biotech filings at SEC.gov ↗